Successful administration of extended-release buprenorphine in the emergency department.
Am J Emerg Med
; 84: 189.e1-189.e3, 2024 Oct.
Article
en En
| MEDLINE
| ID: mdl-39089938
ABSTRACT
INTRODUCTION:
The ongoing opioid epidemic in the United States has resulted in a substantial increase in overdose deaths and related morbidity and mortality. Given that emergency departments (ED) frequently serve as the initial point of contact for individuals experiencing opioid overdose or seeking treatment for opioid use disorder (OUD), ED clinicians have a pivotal role to play in providing prompt and effective treatment for OUD. While ED clinicians routinely administer sublingual and other transmucosal formulations of buprenorphine, extended-release buprenorphine (BUP-XR) remains underutilized in the ED. CASE REPORT We present a case involving the successful administration of BUP-XR in the ED to a patient experiencing spontaneous opioid withdrawal. The patient tolerated test dosing of sublingual buprenorphine (BUP-SL) and subsequently received BUP-XR in the ED. Following this intervention, the patient was referred to the hospital-affiliated substance use disorder outpatient clinic, where he has since demonstrated successful follow-up and retention in treatment.CONCLUSION:
Our report adds to the existing limited literature on the administration of BUP-XR in the ED and highlights the need for more comprehensive clinician teaching and guidance, as well as the establishment of in-hospital protocols for BUP-XR. Despite these challenges, our case indicates that initiating BUP-XR could be a viable and effective option for ED patients with OUD.Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Buprenorfina
/
Preparaciones de Acción Retardada
/
Servicio de Urgencia en Hospital
/
Antagonistas de Narcóticos
/
Trastornos Relacionados con Opioides
Límite:
Adult
/
Humans
/
Male
Idioma:
En
Revista:
Am J Emerg Med
Año:
2024
Tipo del documento:
Article
País de afiliación:
Estados Unidos